Physician profile
Christopher Gause
NPI 1649733692
$9,583.43
in general payments reported to CMS, 2019-2025
8 companies · $6,275 in 2025
The $6,275 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $172 · 2021: $1,212 · 2022: $203 · 2023: $1,429 · 2024: $292 · 2025: $6,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,219 · Food and Beverage: $2,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,218.97 |
| Food and Beverage | $2,777.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,000.38 | 2022-2025 | Pro, T2 Alpha, Mako |
| Axogen | $2,355.57 | 2025 | |
| Mid-Atlantic Surgical Systems, LLC | $1,324.03 | 2021-2025 | |
| Trimed, INC. | $1,157.84 | 2025 | |
| Smith+Nephew, INC. | $388.87 | 2020-2023 | Polarstem, Redapt, Or3o Dual Mobility |
| Depuy Synthes Sales INC. | $281.77 | 2025 | Na, Va-Lcp, Motoband |
| Medtronic, INC. | $59.20 | 2023 | Aquamantys(Tm) |
| Kci USA, INC. | $15.77 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Gause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.